Heart Failure Hospitalization
In HF, possible longer-term benefits emerge with remote management strategy
Among adults with HF, temporary exposure to a remote patient monitoring strategy was not associated with lower risk for all-cause death or hospitalization compared with usual care, though some longer-term benefits were observed, data show.
Septal reduction therapy tied to reduced readmissions for HF
In patients with obstructive hypertrophic cardiomyopathy, septal reduction therapy was associated with reduced risk for HF readmissions, researchers reported in the Journal of the American College of Cardiology.
Data suggest ‘crystal-clear class effect’ for SGLT2 inhibitor benefits in HF
An analysis of 13 randomized controlled trials of SGLT2 inhibitors showed the class reduced CV death, HF hospitalization and serious adverse events in people with HF, according to data published in The American Journal of Cardiology.
Low household income may predict higher risk for 30-day HF readmission
CHICAGO — Adults with an index HF hospitalization were 20% more likely to be readmitted within 30 days for a HF-specific cause if they lived in a low-income area as opposed to a high-income one, researchers reported.
Sotagliflozin reduces 30-day HF readmission rates in type 2 diabetes
CHICAGO — The dual SGLT inhibitor sotagliflozin reduced 30- and 90-day rates of CV mortality and HF-related events when administered before hospital discharge after an episode of worsening HF, according to new data from the SOLOIST trial.
Intensive treatment strategy after discharge for HF reduces death, readmission at 180 days
CHICAGO — In patients hospitalized for acute HF, an intensive treatment strategy of rapid uptitration of appropriate medications and close follow-up reduced death and readmission at 180 days compared with usual care, researchers reported.
Point-of-care risk tool in ED, rapid outpatient follow-up improves acute HF outcomes
CHICAGO — Use of a point-of-care tool to support clinical decision-making in addition to rapid outpatient follow-up reduced the risk for death or CV hospitalizations for patients with acute HF presenting to the ED.
Intracardiac echocardiography may prevent HF readmission after AF ablation
Intracardiac echocardiography use during ablation for atrial fibrillation reduced readmissions at 90 days by 12%, driven by a 24% decrease in HF‐related admissions, researchers reported.
Combined remote monitoring, consultation reduces CV death, hospitalizations in HF
Telemedicine interventions that include remote disease monitoring and remote consultations may reduce short-term CV-related hospitalization and death risk among adults with HF, researchers reported in a meta-analysis.
Acurate neo TAVR system matches Sapien 3 for clinical outcomes at 3 years
BOSTON — Transcatheter aortic valve replacement with the self-expanding Acurate neo device was similar to the balloon-expandable Sapien 3 device in clinical outcomes at 3 years, according to new data from the SCOPE I trial.